STOP-HAE: A Phase 3 Study of ADX-324 in HAE — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

STOP-HAE: A Phase 3 Study of ADX-324 in HAE — Stella

Recruiting

Back to Hereditary Angioedema trials

Phase 3 — Large-scale testing across thousands of people, comparing the new treatment against current standard treatments.

Trial locations(14 sites)

United States

ADARx Clinical Site, Little Rock, Arkansas

ADARx Clinical Site, Walnut Creek, California

ADARx Clinical Site, Wheaton, Maryland

ADARx Clinical Site, Detroit, Michigan

ADARx Clinical Site, St Louis, Missouri

Key details

Phase

Large-scale testing

Sponsor

ADARx Pharmaceuticals, Inc.

Enrollment target

~90 participants

Started

August 2025

Primary completion

June 2027

Age range

18 Years and older

Last updated March 2026

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov